The FasterCures Track: February 2013 - Find out the top 10 medical trends to watch in 2013
Today, we launch the monthly FasterCures Track to keep you posted on our programs and policy activities as they develop. Through the Track, we will provide you with insights, updates, and valuable information that might help you advance your own research and development objectives.
Use as you see fit, share freely, and let us know what you'd like to see featured in this monthly update. Key dates to flag this month:
- February 6 - Hill Briefing on the Blueprint of Medical Research
- February 20 - Webinar on Congress and Medical Research Funding
FasterCures Program Updates
The FasterCures social media campaign TIME=LIVES now features nearly 100 compelling personal stories. Each powerful story makes a strong case for why research matters; collectively, these stories are a call-to-action to make medical research a national priority.
Our goal is to share these stories effectively and amplify their messages to remind our policy makers of medical research's critical value.
View more of these stories:
Also, feel free to download and share TIME=LIVES infographics and help us spread the word.
Policy & Process
Our goal: Improve research processes and develop policies that will better support efficient development and approval of new therapies.
To advance our policy goals, we're convening two important events designed specifically for informed, effective medical research advocacy. Join us!
February 6: Hill Briefing: The Blueprint of Medical Research. Please mark your calendars, and call your members of Congress and ask their key health staffers to attend this important briefing we are convening in partnership with Friends of Cancer Research. Here are the details:
The Blueprint of Medical Research: How New Medicines Get from the Lab to the Patient
Wednesday, Feb. 6, 2013, Dirksen Senate Office Building, Washington
- Deborah W. Brooks, Co-Founder and Executive Vice Chairman, The Michael J. Fox Foundation for Parkinson's Research
- N. Anthony Coles, M.D., M.P.H., President, CEO, and Chairman, Onyx Pharmaceuticals
- Francis Collins, M.D., Ph.D., Director, National Institutes of Health
- Margaret Hamburg, M.D., Commissioner, U.S. Food and Drug Administration
- Roy A. Jensen, M.D., Director, University of Kansas Cancer Center
- Michael Milken, Chairman, The Milken Institute, and Founder, FasterCures
- Ellen V. Sigal, Ph.D., Chairperson and Founder, Friends of Cancer Research
- Moderator: Margaret Anderson, Executive Director, FasterCures
This briefing will educate and orient members of Congress, legislative staff, and policy influencers about the vital role federal agencies and each medical research sector play in advancing medical progress. This includes:
- The breadth, depth, and scope of the research funded by the NIH and how this translates into better health outcomes;
- The essential role of the FDA in advancing science and ensuring that patients can access life-saving therapies that are safe and effective;
- The distinct roles these federal agencies, industry, academia, and patient groups can play on their own, and in collaboration with each other, to speed up the time it takes to get new medicines from the lab to the patient.
February 20: Webinar: Congress and Medical Research Funding. This is no garden-variety budget year in Washington - a tsunami of budget and fiscal issues threaten federal science programs. While Congress has pushed the date of the "sequester" off until the beginning of March, delaying the prospect of automatic 8.2 percent cuts in the budgets of NIH, FDA, and other agencies, it is not entirely off the table. Current funding for these programs expires in March, the fiscal year 2014 budgets are being drafted, and there will likely be a fight over the debt ceiling. This Webinar will tell you what you need to know about what could happen on Capitol Hill, when, and who the important players are, including some new faces.
- Ceci Connolly, Managing Director, Health Research Institute, PricewaterhouseCoopers
- Sudip S. Parikh, Ph.D., Vice President and Director, Center for Analytics & Public Health, Battelle
- Carrie D. Wolinetz, Ph.D., Associate Vice President for Federal Relations, Association of American Universities
- Moderator: Margaret Anderson, Executive Director, FasterCures
Also of interest:
- Sequestration Station: We've designed this Web resource to be your one-stop for relevant news, information, and resources about how automatic federal budget cuts will impact the search for cures.
- Celebration of Science: More than 1,000 leaders in medical research, advocacy, the biopharmaceutical industry, philanthropy, and public policy came together last fall for the Celebration of Science series of activities designed to reaffirm the importance of bioscience. You can now watch every Celebration of Science panel and talk, including the panel featuring Earvin "Magic" Johnson's discussion about HIV with Tony Fauci, director of the National Institute of Allergy and Infectious Diseases; presentations at the National Institutes of Health that showcased stunning scientific and technological advances that are beginning to turn today's dreams into tomorrow's cures; the closing dialogue with James Watson; and many more.
Our goal: Facilitate greater access to and more strategic allocation of capital to support results-driven medical research.
FasterCures continues to spotlight novel approaches to financing drug development with our monthly case study series - Fixes in Financing: Novel R&D Funding Models. The series highlights and details a different novel financing mechanism, helping to address the need of the biopharmaceutical industry for novel approaches to early-stage drug development.
Also of interest: The FasterCures report Fixes in Financing: Financial Innovations for Translational Research, which features models of novel approaches to early-stage drug development that better manage risk, lower capital cost, improve research effectiveness, create diverse portfolios, leverage risk-tolerant capital, and access new capital sources.
Our goal: Stimulate innovative collaborations across all sectors - academia, government, industry, investors, and nonprofits - to speed up the time it takes to get new therapies from the lab to patients.
Partnering for Cures Highlights. Each year, in New York City, FasterCures brings together nearly 1,000 of the most forward-thinking innovators. Summaries, videos, and presentations from the 2012 event - our largest, most energetic crowd yet - are now online. Partnering for Cures is two days of intensive solutions-focused dialogue and networking that provides participants with connections and relationships that will last for years to come - and for many, have already yielded favorable results.
It's never too early to plan ahead. P4C this year will be held Nov. 3-5, 2013, at the Grand Hyatt New York. We're counting the days. Really.
TRAIN: The Research Acceleration and Innovation Network.
Are you a nonprofit disease research foundation? Do you partner with nonprofit funders of research? Or do you have tools that would be useful to a patient-driven, outcomes-focused medical research community? If so, we invite you engage with TRAIN:
- Subscribe to TRAIN E-News, our monthly electronic newsletter, by sending an e-mail to email@example.com with "subscribe" in the subject line.
- Suggest items for TRAIN E-News that are of interest to the nonprofit medical research community, such as cross-sector research partnerships or innovative approaches to research design and funding.
- Submit a tool, resource, or publication to share with the research community by sending an e-mail firstname.lastname@example.org. Topics include venture philanthropy, deal-making, collaboration, and commercialization of scientific discoveries.
- Participate in upcoming Webinars or watch free, archived Webinars and register for upcoming ones. You'll hear experts discuss intellectual property, the reproducibility of research results, engaging with the FDA, and more.
To learn more about the FasterCures TRAIN, visit www.fastercures.org/train.
If you have questions or would like more information about any of the items above, please contact email@example.com.